| |
ORa
|
95% Confidence interval
|
|---|
|
Age (quintiles)
|
|
<=71 años (reference)
|
1
| |
|
72 - 78
|
0.86
|
0.68-1.08
|
|
79 - 82
|
0.71
|
0.55-0.92
|
|
83 - 86
|
0.81
|
0.63-1.05
|
|
87+
|
0.50
|
0.37-0.68
|
|
Socio economic deprivation index
|
|
1 (less disadvantaged)
|
1
| |
|
2
|
1.55
|
1.24-1.94
|
|
3
|
0.99
|
0.78-1.25
|
|
4
|
0.68
|
0.52-0.88
|
|
5 (more disadvantaged)
|
0.41
|
0.30-0.56
|
|
Patients requiring home care
|
0.71
|
0.56-0.88
|
|
Obesity
|
0.68
|
0.55-0.85
|
|
Drug therapy for heart failure
|
|
ACE inhibitor or ARBb
|
1.25
|
1.02-1.53
|
|
Beta-blockers
|
1.23
|
1.01-1.51
|
|
Loop diuretics
|
0.59
|
0.49-0.71
|
-
aOdds ratio adjusted by gender, hypertension, diabetes, hypercholesterolemia, smoking habit, coronary heart disease, atrial fibrillation, stroke, peripheral artery disease, and previous hospitalization for heart failure
-
b
ACE angiotensin converting enzyme, ARB Angiotensin Receptor Blocker
